Symrise stock: Bernstein keeps EUR 99 target for Symrise stock
Published on 10/22/2026 at 18:21 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSAnalyst target and reporting date
- Bernstein kept its EUR 99.00 target for Symrise on October 20, 2026.
- Symrise reported EUR 4.929 billion in revenue for fiscal year 2025.
- Symrise stock costs EUR 102.85 at Lang & Schwarz on October 22, 2026, up 0.54 percent versus the Xetra close.
- Symrise is scheduled to publish its third-quarter 2026 update on October 28, 2026.
Bernstein analyst James Hooper maintained a Neutral rating for Symrise and kept the EUR 99.00 price target on October 20, 2026, according to MarketScreener. The target is EUR 3.85 below the Lang & Schwarz price of EUR 102.85, while the stock was up 0.54 percent versus the Xetra close of EUR 102.30 on October 22, 2026.
Revenue sets the operating base
Symrise's investor-relations page reports revenue of EUR 4.929 billion for fiscal year 2025, organic growth of 2.80 percent and an EBITDA margin of 21.90 percent excluding the impairment of its associated company Swedencare. The same page lists 12,700 employees, more than 6,000 customers and more than 35,000 products. These figures show the scale against which the October analyst view must be assessed.
Stock sits at its yearly high
The stock's 52-week range is EUR 64.70 to EUR 102.85 as of October 22, 2026, putting the Lang & Schwarz quote at the upper end of that range. MarketScreener lists a first-half 2026 change of 47.07 percent and the finance quote shows volume of 394,148 shares on October 22, 2026. The daily move is modest beside the longer-term advance.
Valuation and next company date
The latest structured quote gives Symrise a P/E ratio of 38.42 and a market capitalization of EUR 14.0 billion on October 22, 2026. Bernstein's EUR 99.00 target is below the current euro quote, so the Neutral rating offers a valuation counterweight to the stock's position near its 52-week high. Symrise's investor-relations calendar schedules the third-quarter 2026 update for October 28, 2026, alongside a virtual management roadshow.
Comparison with peers
Symrise: up 0.54 percent versus the Xetra close, P/E 38.42, market capitalization EUR 14.0 billion on October 22, 2026.
Givaudan: up 0.33 percent on SIX in CHF, P/E 29.51, market capitalization CHF 36.7 billion on October 22, 2026.
DSM-Firmenich: up 0.88 percent on Euronext Amsterdam in EUR, negative P/E 22.57, market capitalization EUR 26.6 billion on October 22, 2026.
Price holds above the Xetra close
Symrise remained close to its 52-week high while trading above the Xetra close after the regular session. The analyst target, the valuation multiple and the October 28 reporting date give investors three concrete markers for the next assessment.
Symrise was trading at EUR 102.85 at Lang & Schwarz on October 22, 2026 at 6:13 p.m. CEST, up 0.54 percent versus the Xetra close of October 22, 2026 at EUR 102.30. The further course of trading is shown by the continuously updated real-time quote of Symrise stock.
Symrise stock facts
- Company: Symrise AG
- ISIN: DE000SYM9999
- Ticker: SY1
- Primary exchange: Xetra
- Price Lang & Schwarz as of October 22, 2026 at 6:13 p.m. CEST: EUR 102.85
- Change versus Xetra close: plus 0.54 percent
- Xetra close October 22, 2026: EUR 102.30
- Market capitalization: EUR 14.0 billion as of October 22, 2026
- 52-week range: EUR 64.70-102.85 as of October 22, 2026
- Sector / Industry: Basic Materials / Specialty Chemicals
- Next earnings date: October 28, 2026
Market context: Market report DAX.
